Literature DB >> 15862754

In situ breast cancer: incidence trend and organised screening programmes in Italy.

Alessandro Barchielli1, Massimo Federico, Vincenzo De Lisi, Lauro Bucchi, Stefano Ferretti, Eugenio Paci, Antonio Ponti, Eva Buiatti.   

Abstract

The effect of mammography screening programmes on the incidence of in situ breast cancer (CIS) is described by analysis of the CIS incidence trend in the 1990s and comparison of pre-screening and screening periods in six areas of Italy. All 1069 CIS arising in women aged 40-79 years between 1988 and 1999 were analysed through age-standardised rates and Poisson regression models. The results show that, for the whole series, ductal carcinoma in situ (DCIS) represented 89% and lobular carcinoma in situ (LCIS) 11% of CIS detected. For all six areas, the introduction of screening increased the incidence of DCIS (screening/pre-screening ratio, range 1.12-1.77). Overall, DCIS represented 11% (226/2022) of all screening-detected cancers. A significant increasing trend in DCIS incidence during the 1990s and a modification in pattern of age-specific incidence rates after the beginning of screening programmes were observed. This increase can largely be explained by screening programmes. The incidence observed during the screening period was a persistent 39% higher than during the pre-screening period, after adjustment for the "percentage of cases diagnosed by screening". The increase also involves women at an age not targeted by screening programmes. In conclusion, as the increasing trend in DCIS is not completely explained by the effect of the screening programmes, this supports the use of mammography as a "spontaneous" preventive practice during ongoing organised screening programmes, particularly among age groups not usually invited for screening. Therefore, the effect of mammography on stage-specific incidence of CIS may be more marked than expected on the basis of the effect of screening programmes.

Entities:  

Mesh:

Year:  2005        PMID: 15862754     DOI: 10.1016/j.ejca.2004.12.032

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

Authors:  Elsebeth Lynge; Antonio Ponti; Ted James; Ondřej Májek; My von Euler-Chelpin; Ahti Anttila; Patricia Fitzpatrick; Alfonso Frigerio; Masaaki Kawai; Astrid Scharpantgen; Mireille Broeders; Solveig Hofvind; Carmen Vidal; Maria Ederra; Dolores Salas; Jean-Luc Bulliard; Mariano Tomatis; Karla Kerlikowske; Stephen Taplin
Journal:  Eur J Cancer       Date:  2013-09-13       Impact factor: 9.162

2.  Characteristics of mammography facility locations and stage of breast cancer at diagnosis in Chicago.

Authors:  Elizabeth Tarlov; Shannon N Zenk; Richard T Campbell; Richard B Warnecke; Richard Block
Journal:  J Urban Health       Date:  2008-10-30       Impact factor: 3.671

3.  Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.

Authors:  Cristiana Vidali; Orazio Caffo; Cynthia Aristei; Filippo Bertoni; Alberto Bonetta; Marina Guenzi; Cinzia Iotti; Maria Cristina Leonardi; Salvatore Mussari; Stefano Neri; Nicoletta Pietta
Journal:  Radiat Oncol       Date:  2012-10-25       Impact factor: 3.481

4.  Trends of population-based breast cancer survival in Germany and the US: decreasing discrepancies, but persistent survival gap of elderly patients in Germany.

Authors:  Bernd Holleczek; Hermann Brenner
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

5.  Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.

Authors:  Marta Román; Montse Rué; Maria Sala; Nieves Ascunce; Marisa Baré; Araceli Baroja; Mariola De la Vega; Jaume Galcerán; Carmen Natal; Dolores Salas; Mercedes Sánchez-Jacob; Raquel Zubizarreta; Xavier Castells
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.